|

Pembrolizumab infusion Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Checkpoint blockade administration, Keytruda

Philadelphia, Pennsylvania2 trials

Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Abramson Cancer Center at University of Pennsylvania

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.